Triple agonists of the GLP1 / GIP / NPY2 receptors
PA95460A1Pending Publication Date: 2026-09-09BOEHRINGER INGELHEIM INT GMBH
0 Cites 0 Cited by
Patent Information
- Application Number
- PA95460
- Authority / Receiving Office
- PA · PA
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-30
- Publication Date
- 2026-09-09
Abstract
Hybrid polypeptides that are agonists of the GIP, GLP-1, and neuropeptide Y2 (NPY2) receptors and their medical use in the treatment of a variety of diseases, conditions, or disorders, such as obesity, diabetes, and / or NASH. The polypeptides have the general structure Z1-Z2-Z3, where Z1 is a hybrid polypeptide that agonistizes both GIPR and GLP1R, Z2 is a linker, and Z3 is a polypeptide that agonistizes HY2R.
Need to check novelty before this filing date? Find Prior Art